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Abstract
Objectives This study reports the prevalence of
persistent amblyopia (post-traditional treatment age)
in schoolchildren in the Republic of Ireland (henceforth
Ireland) and Northern Ireland (NI), UK; populations with
broadly similar refractive and genetic profiles but different
eye-care systems.
Design This is a population-based observational study of
amblyopia and refractive error.
Setting Recruitment and testing in primary and postprimary schools in Ireland and NI.
Participants Two groups identified through random
cluster sampling to represent the underlying population;
Ireland 898 participants (12–13 years old) and NI 723
participants (295 aged 9–10 years old, 428 aged 15–
16 years old).
Main outcome measures Monocular logMAR visual
acuity (presenting and pinhole), refractive error
(cycloplegic autorefraction), ocular alignment (cover test)
and history of previous eye care. These metrics were
used to determine prevalence and type of amblyopia and
treatment histories.
Results Children examined in NI between 2009 and
2011 had a significantly lower amblyopia prevalence
than children examined in Ireland between 2016 and
2018 (two-sample test of proportions, p<0.001). Using
a criteria of pinhole acuity 0.2logMAR (6/9.5 Snellen)
plus an amblyogenic factor, 4 of 295 participants aged
9–10 years old (1.3%, 95% CIs 0.4 to 3.6) and 3 of 428
participants aged 15–16 years old (0.7%, 95%CIs 0.2 to
2.2) were identified in NI. The corresponding numbers
in Ireland were 40 of 898 participants aged 12–13 years
old (4.5%, 95% CI 3.2 to 6.1). In NI strabismic amblyopia
was the most prevalent type of persistent amblyopia,
whereas anisometropic was predominant in Ireland. In
Ireland, amblyopia was associated with socioeconomic
disadvantage (OR=2.2, 95%CIs 1.4 to 3.6, p=0.002) and
poor spectacle compliance (OR 2.5, 95% CIs 2.0 to 3.2,
p<0.001).
Conclusions Amblyopia prevalence persisting beyond
traditional treatment ages was significantly lower
among NI children compared with Ireland. Uncorrected
anisometropia, compliance with spectacle wear and
socioeconomic disadvantage were contributing factors in
Ireland. Children without obvious visible eye defects were

Strengths and limitations of this study
►► This report is the first to profile and compare the

prevalence of a treatable deficit of vision that develops in childhood (amblyopia) among children
living in Ireland and Northern Ireland (NI), UK; two
populations with similar refractive, demographic
and genetic profiles but different public health and
eye-care systems.
►► An observational, population-based approach with
random cluster sampling and comparable methodologies was used to obtain sufficiently large data
sets from the two cohorts in Ireland and NI, allowing
a direct comparison of prevalence.
►► The randomly selected population-based recruitment protocols eliminate the potential bias associated with clinical samples.
►► The participants in the Ireland (12–13 years old) and
NI (9–10 and 15–16 years old) cohorts, while different age categories, were all older than the age
range where treatment is effective (that is treatment
before the age of 8 years).
►► Pinhole vision was used as a surrogate for best-corrected vision.
less likely to access eye care in Ireland, resulting in missed
opportunities for intervention where necessary.

Introduction
This paper reports on the first-ever amblyopia
prevalence study in Ireland and compares
findings with Northern Ireland (NI). Amblyopia, often referred to as ‘lazy eye’, is a relatively common, sight-threatening, but mostly
treatable deficit of monocular, and occasionally, binocular vision.1 It results from anomalous visual experience during the critical
period of visual development in the early years
of childhood2 and may affect multiple aspects
of visual function.2–4 For example, untreated
amblyopia does not self-rectify,5 impacts
reading skills6 and significantly increases the
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sensitive visual acuity tests.19 While school-entry vision
screening recommendations and protocols are similar in
both countries (table 1), there are important differences
in terms of coverage, the postfailure pathway and the
context in which the public health systems operate. Specifically, in NI all children are offered vision screening and
children up to the age of 16 years (and up to 19 years if still
in education) are entitled to free eye examinations and a
voucher towards the cost of spectacles through self-referral
to community (high street) optometry. Prompt referral
to the hospital eye service for secondary care treatment
can be initiated directly, with the cost of eye patches for
occlusion therapy covered if required. In contrast, in order
to obtain free eye care and a voucher towards the cost of
spectacles in Ireland, children are referred into the public
health system, where care is offered by ophthalmologists
either in public hospital outpatients departments or in
community healthcare clinics. The recent Health Service
Executive review evaluating eye care services in Ireland
identified concerns regarding capacity in public eye care
services and the uniformity and reach of childhood vision
screening.20
The purpose of this study is to report and compare the
prevalence and cause of persistent amblyopia post-traditional treatment age (8 years)5 21 in two broadly similar
population cohorts (in Ireland and NI) with an equivalent genetic profile and similar refractive error prevalence,22 but different healthcare systems.

Table 1 A summary of public health service funded school-entry vision screening protocols and paediatric eye care services
in Ireland and Northern Ireland
Age

Ireland

Northern Ireland (UK)

School entry 4–5 years

Monocular vision assessment at 5 years
(Snellen 3M chart or logMAR crowded
3M chart) is conducted by the school
nurse.
Pass: Vision of 0.2logMAR in both eyes.
Fail: Vision worse than 0.2logMAR in one
or both eyes or failure to complete the
test.
Failed vision screening referred to
hospital-based ophthalmology/
community ophthalmology for follow-up.
Children remain in this system for review
until discharged at age 12–16 years.20
Once an eye examination is carried out
in a hospital or community health clinic,
children under the age of 12 years can
apply for a voucher which will cover
the cost of basic frames and lenses.
Eye patches for occlusion therapy are
not provided free of charge; this cost is
covered by the parents.
If concerned, contact the general
practitioner or public health nurse for
a referral to a local ophthalmology
department.

Monocular vision assessment at 4–5 years
(logMAR crowded 3M chart) is conducted by
the school nurse.
Pass: Vision of 0.2logMAR in both eyes.
Fail: Vision worse than 0.2logMAR in one or
both eyes or failure to complete the test.
Failed vision screening referred to hospital
eye service (orthoptist, optometrist,
ophthalmology) for follow-up. The
recommended maximum treatment duration
(treatment pathway) for refractive amblyopia
is 38 weeks and for strabismic amblyopia 78
weeks; with children discharged to the care of
their community optometrist once treatment is
complete.19
All children are entitled to a voucher which
covers the price basic spectacles and lenses.
The cost of eye patches for amblyopia
treatment is covered by the National Health
Service.

Post-school entry

2

Attend high street optometrist (free of charge
for all children under 16 years and under 19
years if still in education) and referred onto
tertiary care with ophthalmology if indicated.
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risk of severe visual impairment of both eyes in later life.4 7
Amblyopia may affect an individual’s quality of life, sports
involvement,8 9 self-esteem,10 educational attainment4
and career choice.10 Annual lost earnings in the USA due
to amblyopia have been estimated at $7 billion.11 Due to
the nature of the condition, treatment in early childhood
(before the age of 8 years),12 13 when there is potential to
improve vision, is essential.12–14
Amblyopia has a variety of causes: strabismic (ocular
misalignment), anisometropic (a significant difference
in refractive error between fellow eyes), form deprivation
(exclusion of all visual information except light due to
physical obstructions such as corneal/lenticular opacification or eyelid ptosis), significant uncorrected refractive
error (high levels of astigmatism or hyperopia) or a combination of these features.1 15 Anisometropic amblyopia is
asymptomatic in younger children, due to the clear image
in the non-amblyopic eye, and this coupled with the lack
of any obvious physical signs (straight eyes) can delay diagnosis4 16 and is associated with poorer compliance with
treatment and spectacle wear.17 Although less common,
high degrees of uncorrected refractive error in both eyes
can result in bilateral (in both eyes) amblyopia.18
In Ireland and NI, publicly funded vision screening
programmes to detect reduced vision are recommended at
school entry. Conducting screening at this age (4–5 years)
balances the impetus for early identification of visual deficits in order to implement the most effective treatment
with the need for children to cooperate with appropriately

Open access

2.

3.

4.

5.

6.

7.

(http://www.thomson-software-solutions.com/html/
test_chart_2000.html).
Ocular alignment was evaluated using a cover–uncover
test and an alternating cover test using an accommodative target with and without spectacle correction (if
worn) in the distance (3 m) and near (40 cm IES and
33 cm NICER).
Cycloplegic autorefraction, at least 20 min postinstillation of anaesthetic (Minims Proxymetacaine Hydrochloride 0.5% w/v, Bausch & Lomb, UK) and cycloplegic eye drops (Minims Cyclopentolate Hydrochloride
1% w/v, Bausch & Lomb).
Direct dilated ophthalmoscopy examination of the anterior segment and the lens vitreous and fundus was
carried out on all participants in Ireland and any abnormalities were noted.
Parents/legal guardians completed a participant and
parental history and a children’s lifestyle questionnaire
detailing, inter alia, history of eye surgery, history of occlusion therapy and spectacle wear and whether participants had their eyes tested with an ophthalmologist or
optometrist within 12 months before data collection.
Public involvement: the IES study questionnaire was
based on the NICER study questionnaire with input
from epidemiology, dietetics and focus group feedback. The questionnaire was refined following multisite
user testing, which involved a cognitive walkthrough
evaluation to assess the burden associated with and the
time to complete the questionnaire.25 Following focus
group feedback, a storyboard which outlined the IES
examination was designed to make the study clear to
children; the questionnaire was shortened by removing non-essential questions and simplifying the wording of the remaining questions to maximise accessibility; and a statement advising parents/guardians to skip
any questions they felt uncomfortable answering was
added to the document.
Follow-up: subsequent to the examination, all parents
or legal guardians involved in both studies received a
detailed report advising them of study findings and the
necessity of any further treatment if required.

Procedures
Children with written informed consent and child assent
were examined on their school premises within school
hours. Experimental techniques and methodology
employed in both the NICER study and the IES have been
described in detail elsewhere.22–24 In summary, both the
NICER study and the IES examination involved:
1. Distance monocular crowded logMAR unaided and
presenting (with spectacles if worn) visual acuities
were measured and scored by-letter with and without
a pinhole.
IES—using the Good-Lite (Elgin, Illinois, USA) Sloan
letters logMAR chart. A light metre was employed to
ensure the test luminance did not fall below 120 cd/
m2; and the NICER study—logMAR chart on the Test
Chart 2000, a Windows-based electronic test chart

Definitions
To facilitate comparison with previous studies, amblyopia
prevalence in this study was analysed and presented using
two definitions:
Criteria (A) Multiethnic paediatric eye disease study
(MEPEDS) definition: Unilateral amblyopia; ≥2 line
interocular difference in visual acuity, measured through
a pinhole, with BCVA of 0.2logMAR (6/9.5 Snellen,
20/32) or poorer in the worse eye in the presence of
a unilateral amblyogenic factor consistent with the
affected eye. Amblyogenic factors included strabismus
at a distance and near fixation with/without spectacle
correction, a history of strabismus surgery, anisometropia
(≥1.00 D difference in hyperopia, ≥3.00 D difference
in myopia, ≥1.50 D difference in astigmatism in any
meridian).26
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Methods
This study was a component of the Ireland Eye Study (IES)
and the Northern Ireland Childhood Errors of Refraction (NICER) study, both observational population-based
studies of visual status among schoolchildren in Ireland
and NI. Ethical approval for the IES (20150305-Siofra
Harrington, Ref 15–03) and NICER study (REC/05/121)
was obtained from the Technological University Dublin
Research Ethics Committee and the Ulster University
Research Ethics Committee, respectively, with both
studies adhering to the Tenets of Helsinki Declaration
of Human Studies. Sampling, recruitment protocols and
participation rates are previously published.22 23 Data
collection took place between 2016 and 2018 in Ireland
and between 2009 and 2011 in NI; best-corrected visual
acuity (BCVA) data presented in the present study are
from phase II (3-year follow-up) of the NICER study as
this metric was not recorded in the initial phase of the
NICER study.
In summary, stratified random sampling was employed
in both studies to obtain representative samples of children in Ireland and NI schools. Schools were categorised by urban/rural status (urban: Ireland 751 of 898
participants (83.6%), NI 414 of 723 participants (57.3%);
rural: Ireland 147 of 898 participants (16.4%), 309 of
723 participants (42.7%)) and socioeconomic status
(disadvantaged: Ireland 108 of 898 participants (12.1%),
NI 337 of 723 participants (46.6%); advantaged: 790
of 898 participants (87.9%), 386 of 723 participants
(53.4%)). Ethnicity was assessed by the study coordinator and confirmed by the parent/guardian response
in the study questionnaire. Both study populations were
predominately white (NICER 98%, IES 88.4% white and
the remainder 11.6% were non-white (East Asian 3.3%,
South Asian 1.7%, black 5.5%, Arab 1.1% combined)).
Only data from participants at an age beyond which treatment is likely to be successful (>8 years old)12–14 were used
in the present analysis. Participants were 898 participants
aged 12–13 years living in Ireland and 723 participants
(295 aged 9–10 years and 428 aged 15–16 years) living in
NI.

Open access
prevalence and associated factors; participants without
amblyopia were the reference category. The 5% level of
significance was used throughout; CIs were 95%.

Result: n=716.04
The two-sample test for equality of proportions with
continuity correction was used to compare prevalence
between populations. Logistic regression analysis was
used to examine the relationship between amblyopia

Results
Table 2 displays amblyopia prevalence for the right eye,
left eye, either eye, unilateral and bilateral for both
study groups (Ireland 12–13 years old and NI 9–10 and
15–16 years old) using criteria A and criteria B. All participants in NI were older than the critical treatment age and
as there was no significant difference in amblyopia prevalence between the participants aged 9–10 and 15–16 years
old in NI using either criterion; unless otherwise stated,
amblyopia prevalence refers to amblyopia prevalence in
either eye for participants aged 9–16 years old in NI and
participants aged 12–13 years old in Ireland using criteria
A. Amblyopia prevalence was 4.5% (40 of 898 participants) within the Ireland study (IES). The corresponding
result for the NI (NICER) study participants was 1.0% (7
of 723 participants). Participants in Ireland were significantly more likely to be amblyopic than participants in
NI, OR 4.8 (95%CIs 2.1 to 10.7, p<0.001). Table 2 displays
amblyopia prevalence in 898 Ireland participants aged
12–13 years (second column table 2), and 723 NI participants aged 9–16 years (final column table 2). Amblyopia
prevalence is also presented for the two age cohorts in the
NICER study: 9–10 years old (first column table 2) and
15–16 years old (third column table 2).
The study questionnaire completion rate was between
99.4% (history of spectacle wear and when last examined by an ophthalmologist or optometrist) and 99.7%
(history of eye surgery or amblyopia treatment). Using the
parental questionnaire data, 24 of 40 amblyopic participants (60%) in Ireland had not had their eyes examined
by an eye-care practitioner during the 12 months before
data collection.
Forty-five of 723 NI participants (6.2%) reported a
history of amblyopia treatment, and only 1 of 723 participants aged 9–10 years old (0.02%) remained amblyopic.
In comparison, 68 of 898 participants (7.6%) reported
a history of amblyopia treatment in Ireland; however, of
these, 24 of 898 participants (2.7%) remained amblyopic; 10 of 898 (1.1%) of which had BCVA poorer than
0.6logMAR in their amblyopic eye. While the incidence of
prior amblyopia treatment did not differ between studies
(p=0.61), successful treatment outcomes were significantly poorer in the Ireland study (p<0.001).
In Ireland, 12 of 898 participants (1.3%) reported a
history of strabismus surgery; 8 of 898 (0.9%) of which
were not categorised as having persistent amblyopia;
a history of strabismus surgery was not associated with
persistent amblyopia in Ireland (p=0.25). All participants
in Ireland with a history of eye surgery reported having
attended an ophthalmologist or optometrist for review
within 12 months of participation in the present study.
Table 3 presents the prevalence of anisometropia
and strabismus in Ireland and NI studies, including
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Statistical methodology
The authors collected the primary data which were
entered into databases which were used for subsequent
analysis. The NICER study used Intercooled Stata V.9.2
(StataCorp, Texas, USA). The Statistical Package for
Social Sciences (SPSS) V.24.0 was used for most analyses in
the IES. The statistical programming language R, RStudio
V.1.1.456 (R Foundation for Statistical Computing,
Vienna, Austria), was used to generate random numbers
for the sampling procedure, to provide prevalence data
CIs and for comparing the prevalence of amblyopia,
anisometropia, strabismus, spectacle wear and history of
amblyopia treatment between the two populations, and
to calculate the OR for amblyopia plus CIs. The sample
sizes required (n=716 in both cohorts) were based on a
predictive amblyopia prevalence of 1.9% (which included
those previously treated for amblyopia), in predominately
European Caucasian Australian 12 years old,29 with a
0.95 confidence level and a 0.01 precision estimate. The
sample size was estimated as follows using Cochran’s
sample size formula30: n=sample size,
Z=1.96 with confidence level=0.95 (for alpha=0.05),
d=desired precision of estimate=0.01,
P=0.019 (the estimated proportion)
	

n=

[(

1.96

)(

)(
)]
0.019 1−0.019
(
)
0.01
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Bilateral amblyopia: BCVA poorer than 0.3logMAR
(6/12 Snellen, 20/40) in both eyes in the presence of a
bilateral amblyogenic factor.26
Criteria (B) Refractive error study in children (RESC) definition: Amblyopia was defined as BCVA (measured through
a pinhole) ≥0.3logMAR (≤6/12 Snellen, 20/40) in at
least one eye associated with one or more of the following
potential causes: (1) esotropia, exotropia or vertical
tropia at 4 m fixation, or esotropia or vertical tropia at
0.5 m (strabismic amblyopia); (2) anisometropia of ≥2D
spherical equivalent refractive error (SER) (anisometropic amblyopia); or (3) hyperopia of ≥6D SER.
Unilateral amblyopia: If only one eye met the criteria.
Bilateral amblyopia: If both eyes met the criteria
separately.27
Participants with a history of amblyopia treatment were
not categorised as having persistent amblyopia unless
they met criteria A or criteria B.
To examine the magnitude of amblyopic visual acuity
deficits, based on the BCVA in the amblyopic eye, severe
amblyopia was defined as BCVA >0.6logMAR.28
All refractive errors were measured using autorefraction under cycloplegia and defined as follows: myopia SER
≤−0.50 dioptre sphere (DS), hyperopia SER ≥+2.00 DS
and astigmatism ≥1.00 dioptre cylinder (DC).22

0.001
0.99

4 (1.3) (0.4 to 3.6)

2 (0.7) (0.2 to 2.6)

2 (0.7) (0.2 to 2.6)

 Either eye

 Unilateral

 Bilateral

0.03

1 (0.3) (0.1 to 2.2)

4 (1.3) (0.3 to 3.2)

2 (0.7) (0.1 to 2.6)

2 (0.7) (0.1 to 2.6)

 Left eye

 Either eye

 Unilateral

 Bilateral
7 (0.8) (0.3 to 1.7)

26 (2.9) (1.9 to 4.3)

33 (3.7) (2.6 to 5.2)

22 (2.4) (1.6 to 3.7)

19 (2.1) (1.3 to 3.4)

5 (0.6) (0.2 to 1.4)

35 (3.9) (2.8 to 5.4)

40 (4.5) (3.2 to 6.1)

23 (2.6) (1.7 to 3.9)

0.15

0.007

0.001

0.01

0.01

0.29

0.002

<0.001

0.02

0.02

P value†

0.00

2 (0.5) (0.1 to 1.9)

2 (0.5) (0.1 to 1.9)

1 (0.2) (0.0 to 1.5)

1 (0.2) (0.0 to 1.5)

0.0

3 (0.7) (0.2 to 2.2)

3 (0.7) (0.2 to 2.2)

2 (0.5) (0.1 to 1.9)

2 (0.5) [0.1 to 1.9]

0.33

>0.99

0.38

>0.99

>0.99

0.33

>0.99

0.62

>0.99

>0.99

15–16 years (n=428) n
(%)(95% CIs)
NI
P value ‡

2 (0.3) (0.1 to 1.1)

4 (0.6) (0.2 to 1.5)

6 (0.8) (0.3 to 1.9)

2 (0.3) (0.1 to 1.1)

2 (0.3) (0.1 to 1.1)

2 (0.3) (0.1 to 1.1)

5 (0.7) (0.3 to 1.7)

7 (1.0) (0.4 to 2.1)

4 (0.6) (0.2 to 1.5)

4 (0.6) (0.2 to 1.5)

9–16 years (n=723) N
(%) (95% CIs)
NI

0.31

<0.001

<0.001

<0.001

0.002

0.63

<0.001

<0.001

0.003

0.003

P value §

*Comparison of amblyopia prevalence between 9–10 years old in NI (295 participants) and 12–13 years old in Ireland (898 participants).
†Comparison of amblyopia prevalence in 12–13 years old in Ireland (898 participants) and 15–16 years old in NI (428 participants).
‡Comparison of amblyopia prevalence between 9–10 years old in NI and 15–16 years old in NI.
§Comparison of amblyopia prevalence between combined age cohorts in NI (9–10 years plus 15–16 years) and 12–13 years old in Ireland; amblyopia prevalence in either eye is in bold.
N, number; NI, Northern Ireland.

0.99

0.04

0.04

1 (0.3) (0.1 to 2.2)

 Right eye

0.07

0.002

2 (0.7) (0.2 to 2.6)

 Left eye

23 (2.6) (1.7 to 3.9)

12–13 years (n=898) n
(%) (95% CIs) Ireland
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Criteria B (RESCS)

0.08

2 (0.7) (0.1 to 2.6)

0.08

P value*

 Right eye

Criteria A (MEPEDS)

Amblyopia

9–10 years (n=295) n
(%) (95% CIs)
NI

Table 2 Amblyopia prevalence in 898 participants aged 12–13 years old in Ireland, 294 participants aged 9–10 years old, 428 participants aged 15–16 years old in
Northern Ireland and the combined Northern Ireland participants aged 9–16 years old
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Anisometropia
strabismus status

9–10 years (295)
Prevalence (%, CIs)
NI

P value*

12–13 years (898)
Prevalence (%, CIs)
IRELAND

P value†

15–16 years (428)
Prevalence (%, CIs)
NI

Anisometropia
Strabismus

26 (8.8) (6.0 to 12.8)

0.27

102 (11.2) (9.4 to 13.7)

0.59

43 (10.2) (7.4 to 13.4)

17 (5.8) (3.5 to 9.2)

0.35

38 (4.2) (3.1 to 5.8)

0.68

21 (4.9) (3.1 to 7.5)

Anisometropia+strabismus 4 (1.4) (0.5 to 3.9)

0.99

13 (1.4) (0.8 to 2.5)

0.61

4 (0.1) (0.2 to 3.8)

Strabismus only

13 (4.4) (2.6 to 7.4)

0.24

25 (2.8) (1.8 to 4.1)

0.34

17 (4.0) (2.2 to 7.2)

Anisometropia only

22 (7.5) (4.8 to 11.6)

0.25

89 (9.9) (8.1 to 12.1)

0.72

39 (9.1) (5.4 to 14.9)

*Comparison of anisometropia, strabismus and mixed aetiology prevalence between Ireland (12–13 years old) and NI (9–10 years old).
†Comparison of anisometropia, strabismus and mixed aetiology prevalence between the 15–16 years old in the NI study and 12–13
years old in Ireland.
D, dioptre; N, number;NI, Northern Ireland.

participants with and without amblyopia. Table 4 presents the prevalence of hyperopia, myopia, astigmatism,
anisometropia, strabismus and mixed aetiology (coexisting
anisometropia plus strabismus) in the 898 participants
aged 12–13 years old in Ireland and the 723 participants
aged 9–16 years old in NI. There was no significant difference in the prevalence of either anisometropia or strabismus or mixed aetiology (coexisting anisometropia
plus strabismus) between the participants in Ireland and
NI (all p>0.05, see table 3 and table 4). There was no
significant difference in the prevalence of astigmatism
between the Ireland and NI participants. Figure 1 displays
the prevalence of anisometropia, strabismus and mixed
mechanism anisometropia plus strabismus in the 898
participants aged 12–13 years old in Ireland and the 723
participants aged 9–16 years old in NI.
Causes of amblyopia
For those participants classified as having amblyopia in
the Ireland and NI studies, the reasons for amblyopia are
illustrated in table 5.
In Ireland, anisometropia was the most frequent cause
of persistent amblyopia, followed by a combination of
anisometropia and strabismus (mixed aetiology), strabismus only. In the NI study, strabismus was the primary

cause of persistent amblyopia; only one participant had
mixed aetiology, and one participant had anisometropia.
Level of amblyopic visual acuity Nine participants in
Ireland had severe amblyopia (BCVA poorer than
0.6logMAR); all were anisometropic, three also had strabismus and all reported a history of amblyopia treatment.
One NI participant aged 9–10 years old had severe amblyopia; this participant had strabismus, hyperopia and was a
bilateral hypermetropic astigmat with a history of amblyopia treatment.
Bilateral amblyopia In Ireland, five participants had
bilateral amblyopia (criteria A): one had strabismus, one
had mixed aetiology and the remainder refractive error
(hypermetropic astigmatism). In the NI study, two participants (0.3%) had bilateral amblyopia (aged 9–10 years
old); both were orthotropic with uncorrected refractive error (hypermetropic astigmatism). There were no
NICER participants aged 15–16 years old with bilateral
amblyopia.
Spectacle wear The prevalence of spectacle wear was
significantly higher (p<0.001) in NI (61 of 295 participants (20.7%) aged 9–10 years, and 146 of 428 participants (34.1%) aged 15–16 years) compared with Ireland
(123 of 898 participants aged 12–13 years (13.8%)). In

Table 4 Prevalence of refractive error, anisometropia, strabismus, and mixed aetiology in 898 participants aged 12–13 years
old in Ireland and 723 participants aged 9–16 years old in NI

Hyperopia (≥2.00 D)
Myopia (≤−0.50 D)

Ireland (12–13 years) 898
N (%) (95%CIs)

NI (9–16 years) 723
N (%) (95%CIs)

P value

80 (8.9) (7.2 to 11.0)
179 (19.9) (17.4 to 22.7)

94 (13.0) (10.7 to 15.7)
110 (15.2) (12.7 to 18.1)

0.01
0.02

Astigmatism (≥1.00 DC)

143 (15.9) (13.5 to 18.4)

128 (17.7) (15.0 to 20.7)

0.38

Anisometropia (≥1.00 IOD)

102 (11.2) (9.4 to 13.7)

69 (9.5) (7.6 to 12.0)

0.27

Strabismus
Mixed aetiology

38 (4.2) (3.1 to 5.8)
13 (1.4) (0.8 to 2.5)

38 (5.3) (4.0 to 7.2)
8 (1.1) (0.5 to 2.3)

0.40
0.70

D, dioptre; DC, dioptre cylinder; IOD, interocular difference; N, number; NI, Northern Ireland.
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Table 3 Prevalence of anisometropia, strabismus and mixed mechanism anisometropia in Ireland (12–13 years) and NI (9–10
and 15–16 years)

Open access

Ireland, a further 96 of 898 participants (10.7%) did not
have their spectacles in school.
In Ireland, 13 of the 40 amblyopic participants
(32.5%) never had spectacles, of which 1 had strabismus,
and the remainder had uncorrected refractive error
(anisometropia and hyperopic astigmatism). Ten of the
40 amblyopic participants (25.0%) were wearing spectacles, 6 of which had strabismus and 4 had anisometropia.
Seventeen of the 40 amblyopic participants (42.5%) did
not have their spectacles in school, 4 of which had strabismus and the remainder had anisometropia.
Other factors associated with amblyopia
Socioeconomic disadvantage was significantly associated
with amblyopia in Ireland (OR=2.2, 95%CIs 1.4 to 3.6,
p=0.002). Amblyopia prevalence was 9.3% (10 of 108
participants) in socioeconomically disadvantaged participants compared with 3.8% (30 of 790 participants) in
socioeconomically advantaged participants. There was a
larger number of socioeconomically disadvantaged participants in NI (337 of 723 participants 46.6%, compared

Discussion
This report is the first to profile and compare the prevalence of amblyopia in children living in Ireland and NI;
two populations with broadly similar refractive, demographic and genetic profiles but different public health
and eye-care systems. Common methodology, including
cycloplegic refraction, and definitions were applied in
both cohorts, allowing a direct comparison of prevalence.
Both cohorts sample size was sufficient to accurately determine amblyopia prevalence. Furthermore, the randomly
selected population-based recruitment protocols eliminated the potential bias associated with clinical samples.
The greater than 99% questionnaire completion rate was
most likely due to public involvement in the design stage
of the study. These novel data demonstrate that children
living in Ireland are more likely to retain amblyopia into
teenage years compared with children living in NI. Study
findings ought to provide the prevalence estimates necessary to inform public healthcare policy on the resources
required to address amblyopia. Data collection took place
in 2009–2010 in the NICER study phase II and between
2016 and 2018 in Ireland. The impact of any material

Table 5 Causes of amblyopia in either eye for children in Ireland (12–13 years) and NI (9–10 years old, 15–16 and 9–16 years
old combined)
NI (295)
9–10 years n (%)

Ireland (898)
12–13 years n (%)

NI (428)
15–16 years n (%)

NI (723)
9–16 years n (%)

Criteria A (MEPEDS)
 Anisometropia

1 (25)

21 (52.5)

0 (0.0)

1 (14.2)

 Strabismus

2 (50.0)

5 (12.5)

1 (33.0)

3 (43.0)

 Mixed mechanism

1 (25.0)

6 (15.0)

0 (0.00)

1 (14.2)

 Refractive error

0.0

8 (22.5)

2 (66.0)

2 (28.6)

Ocular outcomes

Criteria B (RESC)
 Anisometropia

1 (25)

19 (57.6)

0 (0.0)

1 (16.7)

 Strabismus

2 (50.0)

3 (9.1)

1 (50.0)

3 (50.0)

 Mixed mechanism
 Refractive error

1 (25.0)
0.0

5 (15.2)
6 (21.2)

0 (0.00)
1 (50.0)

1 (16.7)
1 (16.7)

NI, Northern Ireland; n, number.
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Figure 1 The prevalence of anisometropia, strabismus and
mixed aetiology (coexisting strabismus and anisometropia)
in 898 participants aged 12–13 years old in Ireland and 723
participants aged 9–16 years old in Northern Ireland.

with Ireland 108 of 898 participants 12%); however, socioeconomic disadvantage was not associated with amblyopia in the NI study. It should be noted that the definition
of disadvantaged in NI referred to a disadvantaged area
where a school was located,24 whereas the definition of
disadvantaged in Ireland referred to a threshold number
of pupils in a school coming from a disadvantaged area.22
Amblyopia prevalence did not vary with ethnicity in
Ireland (criteria A: white 4.7% (37 of 794 participants),
non-white 2.9% (3 of 104 participants), p=0.41, criteria B:
white 3.8% (30 of 794 participants), non-white 2.9% (3 of
104 participants), p=0.65). All NI participants were white.
Amblyopia was not associated with urban or rural living
in Ireland or NI.

Open access
may be indicative of inadequate vision screening coverage
(Ireland 80%, NI 95%),36 and lack of timely access to
eye care and spectacle correction and compliance with
amblyopia treatment in Ireland.37 For example, amblyopia was associated with socioeconomic disadvantage in
Ireland where the onus is on parents to fund the cost of
eyepatches for amblyopia therapy; in contrast, this cost is
funded by the state in NI.
Similar numbers of children in Ireland and NI had
been previously treated for amblyopia. Approximately
one-third (35.3%, 24 of 68 participants) in Ireland with a
history of amblyopia treatment presented with amblyopia,
indicating poor compliance with treatment or that treatment is taking place too late.38 Furthermore, 10 of those
(17%, 10 of 68) with a history of treatment presented
with vision poorer than 0.6logMAR (6/24 Snellen) in
one eye. In NI, only one child with a history of amblyopia treatment presented with reduced acuities. Delays of
over 2 years between screening and treatment have been
acknowledged in Ireland.20 While Clarke et al found a
1-year delay in commencing treatment does not adversely
affect the visual outcomes of young children with small
interocular acuity differences, the authors concluded
early treatment is associated with better outcomes.39 Also,
following the introduction of free preschool education
in 2010, children in Ireland may be older commencing
primary school than children in NI.40 Thus conducting
vision screening in preschool, as practised in Denmark,41
ought to be considered.
Bilateral amblyopia was uncommon. The prevalence did
not differ significantly between the two cohorts. Although
the numbers were small, bilateral amblyopia has more
severe consequences as vision is significantly impaired in
both eyes (five children in Ireland and two in NI were
below the legal minimum driving vision standard). All but
one of the participants categorised as bilaterally amblyopic were orthotropic; hence, amblyopia may have been
prevented with compliant spectacle wear alone.42
Even though anisometropia and strabismus are traditionally reported as the primary causes of amblyopia internationally,26 27uncorrected astigmatism is also a significant
issue for participants both in NI and Ireland. Astigmatism
prevalence in NI (6–7 years 24.0%, 12–13 years 20.0%)
and Ireland (6–7 years 19.2%, 12–13 years 15.9%) is
high,22 43 and similar to other studies involving genetically
isolated populations, it is significantly associated with
persistent amblyopia in both cohorts.44 However, the low
prevalence of persistent amblyopia found in NI participants in the present study demonstrates that early intervention and treatment can successfully reduce the risk of
developing amblyopia in susceptible children.
In addition to quantifying a significant public health
concern in Ireland, these data are a valuable addition to
the limited literature on amblyopia prevalence, particularly the prevalence of residual amblyopia after treatment. Amblyopia prevalence rates in studies around the
world vary depending on the definitions used and population studied. The RESC reported an overall amblyopia
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socioeconomical and educational changes during the
intervening years should be considered; however, while
there has been an increasing use of technology in education, household living standards have not changed materially over the last decade with less than 0.6% growth per
annum in real wages (allowing for inflation) in Ireland
(www.cso.ie)31 and a 7% loss in real wages in the UK
between 2006 and 2015 according to the International
Labour Organisation.32
The prevalence of two key amblyogenic factors, strabismus and anisometropia, did not differ significantly
between the two cohorts. However, the visual outcome
of children with these conditions was markedly different
in the two countries. Strabismic amblyopia was the most
common type of amblyopia which persisted beyond the
traditional treatment period in the NI group, whereas
anisometropic amblyopia was the most common type of
persistent amblyopia in Ireland. The relatively low prevalence of anisometropic amblyopia and the relatively higher
level of spectacle ownership and compliance among the
NI children compared with their counterparts in Ireland
demonstrate that potential or manifest anisometropic
amblyopes were successfully identified and treated with
spectacles. Participation in NICER phase I may have led
to a heightened awareness among the parents of that
cohort group of the importance of spectacle compliance
and compliance with amblyopia treatment. However,
NICER phase I reported spectacle compliance of 76%
in 6–7 years old and 77% in 12–13 years old, which was
higher than the IES where spectacle compliance was 65%
in 12–13 years old.33 Therefore, spectacle compliance was
higher in NI than Ireland in advance of NICER phase
I. Furthermore, the older age cohort in NICER phase I
of 12–13 years old were older than the critical treatment
period.12 13Also, there was no significant difference in
amblyopia prevalence between the 9–10 years old and
15–16 years old in the NICER phase II. Previous studies
demonstrated that anisometropic amblyopia is typically
amenable to spectacle correction and that early implementation of refractive adaptation protocols is successful
in resolving anisometropic amblyopia in the majority of
children.18 34 35
Early childhood vision screening protocols are designed
to identify reduced vision and are one of the primary
means by which anisometropia without associated strabismus is detected, and hence potential anisometropic
amblyopes identified and offered treatment.19 Parents are
less likely to seek eye care when children have no obvious
signs or symptoms of visual impairment compared with
parents of children who have manifest strabismus.16
However, early recognition of children with reduced
vision at screening is only the first step in identifying and
successfully treating amblyopia. Successful treatment of
amblyopia is age-sensitive; so timely referral for diagnosis
and treatment is key.12 The disparity between the primary
aetiology of residual amblyopia in the Ireland and NI
cohorts, with anisometropia being the primary aetiology
associated with residual amblyopia in children in Ireland,

Open access
Future research which investigates the reasons for
poor spectacle compliance and poor treatment outcomes
in Ireland when compared with NI is important. For
example, longitudinal studies and audits of the present
systems in Ireland and NI to examine the number of
children referred for treatment and the proportion who
attend for follow-up examination, the age at which amblyopia treatment and spectacles wear was initiated and the
duration of and compliance with treatment are indicated
in order to bring amblyopia prevalence in Ireland in
line with NI. Electronic health records would facilitate
analysis and audit of the present healthcare systems and
allow trends to be monitored over time.58 Public eye
health education directed at parents, teachers and the
wider community is essential to promote spectacle and or
amblyopia treatment compliance in vulnerable children.
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Conclusion
This study is the first to report amblyopia prevalence
in Ireland and the UK using robust methodologies and
sampling to obtain a representative sample of children.
The data reveal that school vision screening followed
by prompt follow-up treatment results in successful
outcomes in susceptible children, as evidenced by the
UK participants in NI. The present study also reveals
inequality in children’s visual outcomes in two countries
with an equivalent genetic profile and similar prevalence
of amblyogenic factors but different public health systems
and access to eye care. Children living in Ireland, where
school-entry vision screening coverage is less comprehensive, free eye care less accessible and long waiting times
exist, have a higher prevalence of amblyopia, which was
associated with socioeconomic disadvantage. While most
children in Ireland with visible eye defects were treated,
uncorrected refractive error and poor spectacle compliance were critical issues. Future studies examining the
for poor spectacle compliance in Ireland compared with
NI are recommended. Consideration should be given to
implementing changes, including public eye-care awareness programmes aimed at bringing the visual outcomes
of children in Ireland in line with children in NI.
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prevalence of 0.74%, which ranged from 0.28% in African
participants aged 5–15 years old to 1.43% in Hispanic
participants aged 5–15 years old.27 In studies which
involved Asian populations, amblyopia prevalence
was 0.95% in the Chinese (predominately Han) aged
5–15 years old in the RESC27 which was similar to that
found in Chinese (Hani) aged 7–8 years old (0.97%),
although slightly higher than that reported in Chinese
(Hani) aged 13–14 years old (0.65%).45 In contrast, a
higher amblyopia prevalence was reported in UK participants aged 7 year olds (3.6%)46 and Polish participants
aged 3–12 years old (3.1%).47 Indeed comparison of the
present study’s findings to previous studies in other countries is not straightforward primarily because of the use
of different definitions for amblyopia48 and variations
in study methodology. For instance, similar to the Avon
Longitudinal Study of Parents and Children (ALSPAC),49
pinhole acuity was used as a surrogate for BCVA, which
facilitates comparison of study findings between Ireland
and NI. A recent study demonstrated good agreement
between pinhole acuity and BCVA and recommended
it as a test for visual impairment not correctable with
spectacles. This surrogacy ought to be considered
when comparing results with studies where subjectively
measured BCVA is reported.50 Furthermore, clarification
is needed on whether reported amblyopia prevalence
findings include figures for those previously treated for
amblyopia.29 The present paper reports data relating to
persistent amblyopia in older children after the critical
period during which treatment is usually applied.
Amblyopia prevalence found in NI (9–16 years 1.0%)
was significantly lower than in Ireland (12–13 years 4.5%)
and also than other studies such as the ALSPAC (7 years
3.4%) study46 and the MEPEDS study in the USA (5–7
years Hispanic 3.1%, Asian 1.1%).51 Amblyopia prevalence in NI was comparable to the Sydney Childhood Eye
Study (12 years 0.4%), which rose to 1.9% when participants previously treated for amblyopia were included
and Denmark (11–12 years 1.5%) where preschool vision
screening has been in operation for 30 years.41 Furthermore, the Sydney-based study reported a reduction in
amblyopia prevalence compared with the Blue Mountains
study (also Australian), where 3.9% of the adult participants were diagnosed with amblyopia.29 52 Similarly, amblyopia prevalence decreased from 2.9% in Danish adults53
to 1.5% following the initiation of the Danish preschool
screening programme.41 Likewise, the present study
reports a lower level of amblyopia in NI than that found
10 years previously in a retrospective study involving clinical data, where a 2.02% amblyopia prevalence was found
in 8 years old in NI.54 In contrast, amblyopia prevalence
in Ireland (4.5%) was similar to that found in British military recruits (4.4%) prior to the advent of comprehensive
vision screening and amblyopia treatment in the UK.55
In addition, the Baltimore screening project found an
amblyopia prevalence of 3.9% among socioeconomically
disadvantaged inner-city children in Baltimore,56 with
persistent amblyopia associated with poor compliance.57
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